Active	Status	Sponsor type	Region	Phase	Filter
2 Active 5 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
NurOwn (MSC-NTF) / BrainStorm Cell Therap
2020-002872-11: An open-label study to assess safety and tolerability of NurOwn® in participants with early stage of Alzheimer's Disease	Ongoing	2	40	Europe	NurOwn®, MSC-NTF cells, Injection	Brainstorm Cell Therapeutics, Ltd., Brainstorm Cell Therapeutics, Ltd.	Alzheimer's Disease, Alzheimer's Disease, Diseases [C] - Nervous System Diseases [C10]
NCT04681118: Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS	No Longer Available	N/A		US	NurOwn (MSC-NTF cells)	Brainstorm-Cell Therapeutics	Amyotrophic Lateral Sclerosis
Coronavirus Vaccine / Tel Aviv University, NeoPharm
No trials found